Novel biomarker panel for the diagnosis and prognosis assessment of sepsis based on machine learning

Biomark Med. 2022 Oct;16(15):1129-1138. doi: 10.2217/bmm-2022-0433. Epub 2023 Jan 12.

Abstract

Background: The authors investigated a panel of novel biomarkers for diagnosis and prognosis assessment of sepsis using machine learning (ML) methods. Methods: Hematological parameters, liver function indices and inflammatory marker levels of 332 subjects were retrospectively analyzed. Results: The authors constructed sepsis diagnosis models and identified the random forest (RF) model to be the most optimal. Compared with PCT (procalcitonin) and CRP (C-reactive protein), the RF model identified sepsis patients at an earlier stage. The sepsis group had a mortality rate of 36.3%, and the RF model had greater predictive ability for the 30-day mortality risk of sepsis patients. Conclusion: The RF model facilitated the identification of sepsis patients and showed greater accuracy in predicting the 30-day mortality risk of sepsis patients.

Keywords: biomarkers; diagnosis; machine learning; prognosis; sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • C-Reactive Protein / analysis
  • Humans
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Sepsis* / diagnosis

Substances

  • Biomarkers
  • C-Reactive Protein